Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, blocking access to the study details and attached documents. The error page includes a Home link for navigation.SummaryDifference20%

- Check17 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing Revision: v3.6.6, indicating an updated version of the related documents (e.g., protocol/SAP) without altering the study details.SummaryDifference0.0%

- Check45 days agoChange DetectedSitewide outage warning and the NCBI service delay notice were removed from the page, removing prominent system-status alerts from the study details view.SummaryDifference0.1%

- Check52 days agoChange DetectedA sitewide outage banner and a note about intermittent delays were added, and the revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check74 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4, indicating a software release update for the page. The change is a backend version bump rather than content or data changes on the page.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page now shows Revision: v3.6.3 as the current document version and no longer shows Revision: v3.6.1. This indicates an updated protocol/document is available for reference.SummaryDifference0.0%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.